Price T Rowe Associates Inc Innoviva, Inc. Transaction History

Price T Rowe Associates Inc

$836 Billion
Q2 2024

A detailed history of Price T Rowe Associates Inc transactions in Innoviva, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 55,107 shares of INVA stock, worth $1.11 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

55,107

Previous 51,487 7.03%

Holding current value

$1.11 Million

Previous $785,000 15.16%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$14.4 - $16.4 $52,128 - $59,367	3,620 Added 7.03%	55,107 $904,000
Q1 2024 May 15, 2024	BUY	$14.56 - $16.78 $27,387 - $31,563	1,881 Added 3.79%	51,487 $785,000
Q4 2023 Feb 14, 2024	BUY	$12.32 - $16.27 $16,755 - $22,127	1,360 Added 2.82%	49,606 $796,000
Q3 2023 Nov 14, 2023	BUY	$12.37 - $13.89 $8,720 - $9,792	705 Added 1.48%	48,246 $627,000
Q2 2023 Aug 14, 2023	BUY	$11.39 - $13.72 $14,157 - $17,053	1,243 Added 2.68%	47,541 $606,000
Q1 2023 May 15, 2023	BUY	$10.73 - $13.6 $6,438 - $8,160	600 Added 1.31%	46,298 $521,000
Q4 2022 Feb 14, 2023	BUY	$11.8 - $13.78 $13,369 - $15,612	1,133 Added 2.54%	45,698 $605,000
Q3 2022 Nov 14, 2022	BUY	$11.61 - $15.22 $46,753 - $61,290	4,027 Added 9.93%	44,565 $518,000
Q2 2022 Aug 15, 2022	BUY	$14.32 - $19.88 $31,504 - $43,736	2,200 Added 5.74%	40,538 $598,000
Q1 2022 May 16, 2022	SELL	$15.39 - $20.25 $58,466 - $76,929	-3,799 Reduced 9.02%	38,338 $742,000
Q4 2021 Feb 14, 2022	SELL	$15.91 - $18.72 $9,975 - $11,737	-627 Reduced 1.47%	42,137 $727,000
Q3 2021 Nov 15, 2021	SELL	$13.06 - $17.24 $107,222 - $141,540	-8,210 Reduced 16.11%	42,764 $715,000
Q2 2021 Aug 16, 2021	SELL	$11.45 - $13.96 $136,163 - $166,012	-11,892 Reduced 18.92%	50,974 $684,000
Q1 2021 May 17, 2021	BUY	$11.06 - $12.87 $33,777 - $39,304	3,054 Added 5.11%	62,866 $751,000
Q4 2020 Feb 16, 2021	BUY	$9.33 - $12.48 $558,045 - $746,453	59,812 New	59,812 $741,000

Others Institutions Holding INVA

# of Institutions

223

Shares Held

79M

Call Options Held

20K

Put Options Held

5.4K

View Full List

About Innoviva, Inc.

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.4B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

More about INVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account

Price T Rowe Associates Inc Innoviva, Inc. Transaction History